CD30 ligand could be a new therapeutic target for central nervous system autoimmunity

Koji Shinoda; Yasunobu Yoshikai

doi:10.1111/cen3.12204

CD30 ligand could be a new therapeutic target for central nervous system autoimmunity

Koji Shinoda, Yasunobu Yoshikai

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	111-112
Number of pages	2
Journal	Clinical and Experimental Neuroimmunology
Volume	6
Issue number	2
DOIs	https://doi.org/10.1111/cen3.12204
Publication status	Published - May 1 2015

All Science Journal Classification (ASJC) codes

Neuroscience (miscellaneous)
Immunology
Immunology and Microbiology (miscellaneous)
Clinical Neurology

Access to Document

10.1111/cen3.12204

Cite this

@article{ae7036e05c5f4dd799659c3f4964489c,

title = "CD30 ligand could be a new therapeutic target for central nervous system autoimmunity",

author = "Koji Shinoda and Yasunobu Yoshikai",

year = "2015",

month = may,

day = "1",

doi = "10.1111/cen3.12204",

language = "English",

volume = "6",

pages = "111--112",

journal = "Clinical and Experimental Neuroimmunology",

issn = "1759-1961",

publisher = "John Wiley and Sons Ltd",

number = "2",

}

TY - JOUR

T1 - CD30 ligand could be a new therapeutic target for central nervous system autoimmunity

AU - Shinoda, Koji

AU - Yoshikai, Yasunobu

PY - 2015/5/1

Y1 - 2015/5/1

UR - http://www.scopus.com/inward/record.url?scp=84928952597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928952597&partnerID=8YFLogxK

U2 - 10.1111/cen3.12204

DO - 10.1111/cen3.12204

M3 - Comment/debate

AN - SCOPUS:84928952597

SN - 1759-1961

VL - 6

SP - 111

EP - 112

JO - Clinical and Experimental Neuroimmunology

JF - Clinical and Experimental Neuroimmunology

IS - 2

ER -

CD30 ligand could be a new therapeutic target for central nervous system autoimmunity

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this